Impact of Goreisan upon aquaporin-2-incorporated aquaresis system in patients with congestive heart failure

The efficacy and safety of Wulingsan modified formulas for chronic heart failure patients: a systematic review and meta-analysis

(2022) Ziyun Li et al.   Journal of Thoracic Disease

A systems pharmacology approach to investigate the mechanism of Oryeong-san formula for the treatment of hypertension

(2019) Sang-Kyun Kim et al.   JOURNAL OF ETHNOPHARMACOLOGY

Quantitative evaluation of Oryeongsan and its action on water regulation in renal inner medullary collecting duct cells

(2016) Yun Jung Lee et al.   JOURNAL OF ETHNOPHARMACOLOGY

Oryeongsan inhibits LPS-induced production of inflammatory mediators via blockade of the NF-kappaB, MAPK pathways and leads to HO-1 induction in macrophage cells

(2014) You-Chang Oh et al.   BMC Complementary and Alternative Medicine

Increased Urine Aquaporin-2 Relative to Plasma Arginine Vasopressin Is a Novel Marker of Response to Tolvaptan in Patients With Decompensated Heart Failure

(2014) Teruhiko Imamura et al.   CIRCULATION JOURNAL

Oryeongsan (Wulingsan), a traditional Chinese herbal medicine, induces natriuresis and diuresis along with an inhibition of the renin–angiotensin–aldosterone system in rats

(2012) You Mee Ahn et al.   JOURNAL OF ETHNOPHARMACOLOGY

Efficacy and Safety of Tolvaptan in Heart Failure Patients with Volume Overload Despite the Standard Treatment with Conventional Diuretics: A Phase III, Randomized, Double-blind, Placebo-controlled Study (QUEST Study)

(2011) Masunori Matsuzaki et al.   CARDIOVASCULAR DRUGS AND THERAPY